The online resource that supports patients on their treatment journey
MyEntresto is designed to:
- Reduce the burden of repeat appointments
- Boost understanding of heart failure
- Improve adherence to treatment leading to better patient outcomes1
Whether you are prescribing ENTRESTO® (sacubitril/valsartan) for your chronic HFrEF patients, or are supervising their ongoing treatment, ensuring adherence to their medication is critical. Lack of adherence may be because of improvements in the patient’s symptoms, debilitating side-effects or a busy lifestyle.
To support you in empowering your patients to stay on top of their condition and treatment, with the hope of improving adherence, Novartis has developed MyEntresto in partnership with HF patients: a patient portal dedicated to supporting the ENTRESTO community.
Designed to educate patients about their chronic heart failure/chronic HFrEF and explain how ENTRESTO works; by encouraging use of the portal to your patients, you can improve their confidence and understanding around their treatment. In turn, this can help limit decompensations, reduce burden on the healthcare system,2 and save you time.
The MyEntresto portal forms a key part of our support offering to the wider ENTRESTO community, offering 24/7 patient support and resources.
Its key features include:
Mode of action video
Interactive 3D heart
Opt-in support programme providing relevant and timely emails directing patients to useful information and resources.
Facts and statistics
Tips and advice
Lifestyle modification suggestions, appointment advice and guidance regarding their medication and side effects.
Taken together, the content of the MyEntresto portal aims to increase patient knowledge, breed confidence in their medication and deliver improved adherence. For HCPs, whether prescribers or those supporting patients on treatment, this may mean more meaningful, less frequent appointments and can help to deliver better ENTRESTO patient outcomes.
Click here to access MyEntresto & YourChoice Engage materials, as well as our suite of support materials for you and your patients, on our Resources Page
HCP, healthcare professional; HF, heart failure; HFrEF, heart failure with reduced ejection fraction.
- Aremu TO, et al. Pharmacy (Basel) 2022;10(5):106.
- Roche Diagnostics. Breaking the cycle: Tackling late heart failure diagnosis in the UK. Available online at: https://diagnostics.roche.com/gb/en/products/product-category/cardiac-ca... (Accessed May 2023).